Podcast Episodes
Back to Search
Episode 433: Uromigos Japan - 改訂版ASCO mCRPCガイドライン
5月に改訂されたASCOのmCRPC薬物療法のガイドラインについて3人でディスカッションしました！！評価はいかに？
1 year, 2 months ago
Episode 432: ASCO 2025 Rapid Oral Session RCC/Bladder Recap
Karie Runcie, MD joins us after chairing the ASCO 2025 rapid oral session to discuss the rcc/bladder presentations.
1 year, 3 months ago
Episode 432: Recap of the ASCO Rapid Oral RCC/Bladder Session
Karie Runcie, MD joins us to discuss the ASCO rapid oral rcc/bladder session she moderated at ASCO 2025
1 year, 3 months ago
Episode 431: IMPACT series - Axel Bex on Impactful RCC Clinical Trials
Axel Bex joins the show to discuss trials that he thinks have impacted RCC. We also discuss consolidative approaches, neoadjuvant trials and what can…
1 year, 3 months ago
Episode 430: Structured Exercise Improves DFS/OS after Adjuvant Therapy in Colorectal Cancer - Does This Apply to GU Cancers?
Chris Booth joins the show to discuss his recent NEJM paper that demonstrated significant DFS and OS improvements with a structured exercise program …
1 year, 3 months ago
Episode 429: ASCO2025レポート
ASCO2025の注目演題を取り上げ解説、ディスカッションしました！
1 year, 3 months ago
Episode 428: ASCO 2025 Recap
Brian, Tom and Silke discuss their highlights form ASCO 2025
1 year, 4 months ago
Episode 427: Emerging Data in Non-muscle Invasive Bladder Cancer (NMIBC)
Josh Meeks joins us to give stellar overview of the emerging data in this space. We also discuss the recent ODAC ruling for lower risk patients.
1 year, 4 months ago
Episode 426 - ASCO 2025: AMPLITUDE Phase 3 of PARPi in mHSPC
Gert Attard joins us to discuss this practice-changing data and the highlight of ASCO 2025
1 year, 4 months ago
Episode 425: ASCO 2025 - AI-enabled selection of patients for benefit of ADT + ARPI
Nick James discusses intriguing data from STAMPEDE to us AI to analyze pathology slides to predict benefit from ADT + abiraterone
1 year, 4 months ago